 |
|
Risk of Revision After Vertebral Augmentation for Osteoporotic Vertebral Fracture: A Narrative Review
Shinji Takahashi, Hiroyuki Inose, Koji Tamai, Masayoshi Iwamae, Hidetomi Terai, Hiroaki Nakamura
Neurospine. 2023;20(3):852-862. Published online 2023 Sep 30 DOI: https://doi.org/10.14245/ns.2346560.280
|
|
Citations to this article as recorded by
 Stem Cell and Regenerative Therapies for the Treatment of Osteoporotic Vertebral Compression Fractures
Songzi Zhang, Yunhwan Lee, Yanting Liu, Yerin Yu, Inbo Han
International Journal of Molecular Sciences.2024; 25(9): 4979. CrossRef Comparison of the Clinical Efficacy of Anabolic Agents and Bisphosphonates in the Patients With Osteoporotic Vertebral Fracture: Systematic Review and Meta-analysis of Randomized Controlled Trials
Ikchan Jeon, Sung Bae Park, Bong Ju Moon, Miyoung Choi, Sung Uk Kuh, Jongtae Kim
Neurospine.2024; 21(2): 416. CrossRef Promotion of Bone Formation in a Rat Osteoporotic Vertebral Body Defect Model via Suppression of Osteoclastogenesis by Ectopic Embryonic Calvaria Derived Mesenchymal Stem Cells
Yerin Yu, Somin Lee, Minsung Bock, Seong Bae An, Hae Eun Shin, Jong Seop Rim, Jun-oh Kwon, Kwang-Sook Park, Inbo Han
International Journal of Molecular Sciences.2024; 25(15): 8174. CrossRef Romosozumab versus bisphosphonates for preventing subsequent vertebral fractures after balloon kyphoplasty: comparison using data from two prospective multicenter studies
Hiroyuki Inose, Shinji Takahashi, Masatoshi Teraguchi, Tsuyoshi Kato, Kentaro Yamada, Hiroyuki Yasuda, Masaki Terakawa, Masakazu Minetama, Masaki Tomori, Yukihiro Nakagawa, Toshitaka Yoshii
JBMR Plus.2024;[Epub] CrossRef Optimal Strategies for the Treatment of Osteoporotic Spinal Diseases
Dae-Chul Cho
Neurospine.2023; 20(4): 1095. CrossRef
|